SOURCE: SINCLAIR PHARMA PLC.

October 16, 2007 02:07 ET

Sinclair Pharma plc announces US launch of Aloclair (Ameseal) oral lesion relief spray by OMNI Preventive Care, a 3M ESPE Company

GODALMING, UK--(Marketwire - October 16, 2007) -



Sinclair Pharma plc announces US launch of Aloclair (Ameseal) oral
                       lesion relief spray by
               OMNI Preventive Care, a 3M ESPE Company

16 October, Godalming, UK: Sinclair Pharma plc ("Sinclair"), a specialty pharmaceutical company, announces that Aloclair spray has been launched in the US by OMNI Preventive Care, a 3M ESPE Company.

Aloclair spray has been launched in the US under the brand name Ameseal. Ameseal will be marketed as an Oral Lesion Relief Spray which forms a protective barrier for fast, long lasting pain relief from mouth ulcers, irritations or sores.

Approximately 20% of the general population is affected by mouth ulcers, and they are particularly common in children, women and people over age 65. While many conventional mouth ulcer products contain anaesthetics, which can be painful or difficult to apply, Ameseal/Aloclair offers a new way of managing mouth ulcers. When sprayed onto the ulcer, a barrier is formed that protects the ulcer from painful stimulation by chewing, speaking, food or drink. Ameseal is presented as a convenient, portable pocket pack which can be applied discreetly.

The Aloclair range of products are now sold in 31 countries. OMNI has exclusive rights to promote Ameseal Spray to dental professionals and consumers in the US.

Dr Michael Flynn, CEO of Sinclair Pharma, said:

"OMNI Preventive Care has an excellent presence in the dental market and we welcome the launch of Aloclair spray as Ameseal in the US. We are confident that OMNI will reach consumers through dental professionals and convince them that Ameseal is the product of choice when they have a painful lesion in the mouth."

Kevin Thomas, General Manager of OMNI Preventive Care, added:

"Ameseal will be a great addition to the preventive line of products that we offer to dental professionals. The oral lesion relief category is an important part of our portfolio and we look forward to the benefits that Ameseal can bring to the American Market."

                              -  ends -

For further information please contact:

Sinclair Pharma plc                  Tel:  +44 (0) 1483 410 600
Dr Michael Flynn, CEO
Zoe McDougall, Director of Communications

Capital MS&L
Mary Clark, Halina Kukula            Tel  +44 (0)20 7307 5340

Notes to Editors:

About Sinclair Pharma Plc www.sinclairpharma.com

Sinclair Pharma plc is an international specialty pharmaceutical company. It has a growing sales and marketing operation that is already present in France, Italy, UK, Spain and Portugal, and a complementary marketing partner network that spans more than 65 countries.

Sinclair has proven expertise in acquiring or developing commercially attractive and undervalued products, registering these products and bringing them to market within a short timeframe. The company focuses on niche therapeutic areas and its current portfolio includes products for dermatological conditions and oral health.


"Safe Harbor" Statement under the US Private Securities Litigation Reform Act of 1995: Some or all of the statements in this document that relate to future plans, expectations, events, performances and the like are forward-looking statements, as defined in the US Private Securities Litigation Reform Act of 1995. Actual results of events could differ materially from those described in the forward-looking statements due to a variety of factors.


The Sinclair Portfolio in the US

Aloclair® Spray adds to the portfolio of Sinclair oral health products that are sold in the USA. Decapinol, for dental plaque and gingivitis, is marketed by OraPharma Inc., a division of Johnson & Johnson. Rincinol and Canker-X (for mouth ulcers - sold as Aloclair® in non-US markets are currently marketed by Sunstar Butler in the US. Align Pharmaceuticals sell Numoisyn lozenges and liquid (sold as SST™ and Salinum™ in non-US markets) for xerostomia (dry mouth). Xclair™ Sinclair's product for radiation dermatitis is also licensed to Align Pharmaceuticals. Graceway Pharmaceuticals markets Atopiclair®. Lastly Gelclair™ (for oral mucositis) is licensed to Helsinn Healthcare.

3M Health Care

3M Health Care, one of 3M's six major business segments, provides world-class innovative products and services to help health care professionals improve the practice and delivery of patient care. 3M will continue to grow its vibrant Health Care businesses globally serving multiple market segments. 3M ESPE, a leader in the dental industry, is a part of the 3M Health Care family.

3M ESPE

3M ESPE was founded in 2001 when 3M Dental Products Division and ESPE Dental AG combined with the vision of becoming the leader in the global dental market by providing the highest quality and innovation in products and services designed to help dental professionals help their patients. Led by Jeff Lavers, vice president and general manager, 3M ESPE is one of about 40 businesses that make up 3M, a US publicly held, multinational organization with operations in more than 60 countries. The two companies combine a rich history of business excellence and innovations in dental materials and delivery systems. Through strong research and development programs, they have earned a reputation for quality and reliability in the product and services they offer the dental profession worldwide. The result of the combination is a company that is trusted and recognized worldwide as a source for more than 2,000 dental products and services designed to exceed customer expectations, and a continued adherence to the highest standard of business ethics. 3M ESPE manufactures and markets more than 2,000 products for use in the dental industry to improve the oral health of people around the world. Trusted brands include 3M™ ESPE™ Filtek™ Restorative Materials, 3M™ ESPE™ Impregum™ Impression Materials and 3M™ ESPE™ Pentamix™ 2 Electronic Mixing System, 3M™ ESPE™ RelyX™ brand of Cements, 3M™ ESPE™ Adper™ Prompt™ L-Pop™ Adhesive System and 3M™ ESPE™ Imprint™ 3 VPS Impression Material.

OMNI Preventive Care, a 3M ESPE Company

OMNI Preventive Care helps dental professionals implement protocols that help enhance the quality of care and productivity in the dental hygiene department. OMNI provides a broad range of oral preventive care products and services for use in-office and at-home. OMNI is a wholly-owned subsidiary of 3M ESPE Dental Products. For more information or to set up a staff meeting visit the OMNI web site at www.omnipreventivecare.com or call OMNI at 800-445-3386.





Copyright © Hugin ASA 2007. All rights reserved.

Contact Information